SPY362.66-0.56 -0.15%
DIA298.74-1.69 -0.56%
IXIC12,094.40+57.08 0.47%

Proteostasis Therapeutics Q3 EPS $(0.16) Up From $(0.25) YoY

Proteostasis Therapeutics (NASDAQ:PTI) reported quarterly losses of $(0.16) per share. This is a 36 percent increase over losses of $(0.25) per share from the same period last year.

· 11/16/2020 16:16
Proteostasis Therapeutics (NASDAQ:PTI) reported quarterly losses of $(0.16) per share. This is a 36 percent increase over losses of $(0.25) per share from the same period last year.